Anna Zimmermann

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, with Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients with Bladder Cancer

Hans von der Maase, L. Sengeløv, J.T. Roberts et al. · The Journal of Urology · 2006 · 172 citations

Preclinical Therapeutics, L. Sengelov, Population Health Sciences +19

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

J.T. Roberts, Hans von der Maase, L. Sengeløv et al. · Annals of Oncology · 2006 · 116 citations · Full text

Surgical Oncology, Urology, Genitourinary Cancer +7

Pheromone sensing regulates <i>Caenorhabditis elegans</i> lifespan and stress resistance via the deacetylase SIR-2.1

Andreas H. Ludewig, Yevgeniy Izrayelit, Donha Park et al. · Proceedings of the National Academy of Sciences · 2013 · 98 citations · Full text

Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype

Silvia Selinski, Meinolf Blaszkewicz, Marie-Louise Lehmann et al. · Pharmacogenetics and Genomics · 2011 · 56 citations

Bladder Cancer Epidemiology, Tagging Snp, Genetics +20

Validation of the Functional Assessment of Cancer Therapy–Lymphoma (FACT-LYM) in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Gebra Cuyún Carter, Astra M. Liepa, Anna Zimmermann et al. · Blood · 2008 · 39 citations